Five-Year Outcome of 215 Newly Diagnosed Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib-Based Regimens: A Gimema CML Working Party Analysis

被引：0

作者：

Gugliotta, Gabriele ^{[1
]}

Castagnetti, Fausto ^{[1
]}

Breccia, Massimo ^{[2
]}

Levato, Luciano ^{[3
]}

Rege-Cambrin, Giovanna ^{[4
]}

Luciano, Luigiana ^{[5
]}

Bocchia, Monica ^{[6
]}

Rossi, Antonella Russo ^{[7
]}

Usala, Emilio ^{[8
]}

Salvucci, Marzia ^{[9
]}

Gozzini, Antonella ^{[10
]}

Binotto, Gianni ^{[11
]}

Cedrone, Michele ^{[12
]}

Abruzzese, Elisabetta ^{[13
]}

Avanzini, Paolo ^{[14
]}

Venturi, Claudia ^{[1
]}

Testoni, Nicoletta ^{[1
]}

Soverini, Simona ^{[1
]}

Alimena, Giuliana ^{[2
]}

Cavo, Michele ^{[1
]}

Martinelli, Giovanni ^{[1
]}

Pane, Fabrizio ^{[15
]}

Saglio, Giuseppe ^{[16
]}

Baccarani, Michele ^{[17
]}

Rosti, Gianantonio ^{[1
]}

机构：

[1] Univ Bologna, Sch Med, Bologna, Italy

[2] Univ Roma La Sapienza, I-00185 Rome, Italy

[3] Azienda Osped Pugliese Ciaccio, Catanzaro, Italy

[4] Univ Turin, San Luigi Gonzaga Hosp, Orbassano, Italy

[5] Univ Naples Federico II, Naples, Italy

[6] Univ Siena, I-53100 Siena, Italy

[7] Univ Bari, Bari, Italy

[8] Osped Oncol A Businco, UO Ematol & CTMO, Cagliari, Italy

[9] Osped Santa Maria delle Croci, Ravenna, Italy

[10] AOU Careggi, Florence, Italy

[11] Univ Padua, Padua, Italy

[12] Azienda Osped S Giovanni Addolorata, Rome, Italy

[13] Osped S Eugenio, Rome, Italy

[14] Azienda Osped S Maria Nuova, Reggio Emilia, Italy

[15] Univ Naples Federico II, Naples, Italy

[16] Univ Turin, Osped San Luigi Gonzaga, Dept Clin & Biol Sci, Orbassano, Italy

[17] Univ Bologna, Bologna, Italy

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Hagop M. Kantarjian
Timothy P. Hughes
Richard A. Larson
Dong-Wook Kim
Surapol Issaragrisil
Philipp le Coutre
Gabriel Etienne
Carla Boquimpani
Ricardo Pasquini
Richard E. Clark
Viviane Dubruille
Ian W. Flinn
Slawomira Kyrcz-Krzemien
Ewa Medras
Maria Zanichelli
Israel Bendit
Silvia Cacciatore
Ksenia Titorenko
Paola Aimone
Giuseppe Saglio
Andreas Hochhaus
Leukemia, 2021, 35 : 440 - 453
[32] Better molecular response (MR) to imatinib (IM) in early chronic phase (CP) versus late CP chronic myeloid leukemia (CML) patients (pts) in complete cytogenetic response (CCR): A comparison at 24 months of 2 clinical trials of the GIMEMA working party on CML on behalf of the GIMEMA working party on chronic myeloid leukemia (GIMEMA-CML).
Poerio, A
Amabile, M
Iacobucci, I
Soverini, S
Colarossi, S
Ottaviani, E
Terragna, C
Grafone, T
Luatti, S
Castagnetti, F
Pane, F
Saglio, G
Russo, D
Rosti, G
Baccarani, M
Martinelli, G
BLOOD, 2005, 106 (11) : 319A - 319A
[33] Five-Year Efficacy and Safety of Dasatinib and Imatinib by Baseline Comorbidity and Age in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) from DASISION
Mauro, Michael J.
Cortes, Jorge E.
Hochhaus, Andreas
Shah, Neil P.
Atallah, Ehab L.
Abaskharoun, Mena
Sy, Oumar
Saglio, Giuseppe
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S312 - S313
[34] Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Kantarjian, Hagop M.
Hughes, Timothy P.
Larson, Richard A.
Kim, Dong-Wook
Issaragrisil, Surapol
le Coutre, Philipp
Etienne, Gabriel
Boquimpani, Carla
Pasquini, Ricardo
Clark, Richard E.
Dubruille, Viviane
Flinn, Ian W.
Kyrcz-Krzemien, Slawomira
Medras, Ewa
Zanichelli, Maria
Bendit, Israel
Cacciatore, Silvia
Titorenko, Ksenia
Aimone, Paola
Saglio, Giuseppe
Hochhaus, Andreas
LEUKEMIA, 2021, 35 (02) : 440 - 453
[35] CONTINUED SUPERIORITY OF NILOTINIB VS IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENESTND BEYOND 1 YEAR
Hochhaus, A.
Lobo, C.
Pasquini, R.
Clark, R.
Kim, D. W.
Issaragrisil, S.
le Coutre, P.
Reiffers, J.
Kantarjian, H.
Saglio, G.
Edrich, P.
Hoenekopp, A.
Gallagher, N.
Larson, R.
Hughes, T.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 459 - 459
[36] CHROMOSOMAL ABNORMALITIES IN PHILADELPHIA CHROMOSOME (PH)-NEGATIVE METAPHASES IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC FRONTLINE WITH NILOTINIB OR DASATINIB
Shah, S.
Kantarjian, H.
O'Brien, S.
Borthakur, G.
Burger, J.
Kadia, T.
Pemmaraju, N.
DiNardo, C.
Jabbour, E.
Cortes, J.
HAEMATOLOGICA, 2014, 99 : 337 - 337
[37] Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase
Saydam, Guray
Haznedaroglu, Ibrahim Celalettin
Kaynar, Leylagul
Yavuz, Akif S.
Ali, Ridvan
Guvenc, Birol
Akay, Olga M.
Baslar, Zafer
Ozbek, Ugur
Sonmez, Mehmet
Aydin, Demet
Pehlivan, Mustafa
Undar, Bulent
Dagdas, Simten
Ayyildiz, Orhan
Akkaynak, Diyar Z.
Dag, Ilkiz M.
Ilhan, Osman
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (14) : 1851 - 1858
[38] Impact of age in the outcome of patients with chronic myeloid leukemia in late chronic phase: Clinical and molecular results of a phase II study of the GIMEMA CML working party.
Martinelli, Giovanni
Palandri, Francesca
Iacobucci, Ilaria
Bassi, Simona
Castagnetti, Fausto
Amabile, Marilina
Cilloni, Daniela
Poerio, Angela
Soverini, Simona
Rege-Cambrin, Giovanna
Iuliano, Franco
Alimena, Giuliana
Latagliata, Roberto
Testoni, Nicoletta
Pane, Fabrizio
Saglio, Giuseppe
Rosti, Gianantonio
Baccarani, Michele
BLOOD, 2006, 108 (11) : 286B - 286B
[39] Prospective Metabolic and Cardiovascular Assessment in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib 300 Mg Bid Frontline in the Gimema 0811 Trial
Breccia, Massimo
Castagnetti, Fausto
Gugliotta, Gabriela
Martino, Bruno
Rossi, Giuseppe
Carella, Angelo Michele
Stagno, Fabio
Turri, Diamante
Avanzini, Paolo
Trabacchi, Elena
Pierri, Ivana
Tiribelli, Mario
Isidori, Alessandro
Salvucci, Marzia
Capalbo, Silvana
Merli, Anna
Levato, Luciano
Binotto, Gianni
Maino, Elena
Rupoli, Serena
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Alimena, Giuliana
Rosti, Gianantonio
BLOOD, 2015, 126 (23)
[40] LONG-TERM (10-YEAR) OUTCOME OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH NILOTINIB 400 BID IN FIRST-LINE: FINAL RESULTS OF THE GIMEMA CML 0307 STUDY
Gugliotta, G.
Castagnetti, F.
Breccia, M.
Levato, L.
Intermesoli, T.
D'Adda, M.
Salvucci, M.
Stagno, F.
Cambrin, G. Rege
Tiribelli, M.
Martino, B.
Bocchia, M.
Cedrone, M.
Trabacchi, E.
Cavazzini, F.
Porretto, F.
Sora, F.
Usala, E.
Albano, F.
Martinelli, G.
Soverini, S.
Foa, R.
Pane, F.
Cavo, M.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2019, 104 : 146 - 146

← 1 2 3 4 5 →